The latest announcement is out from Renerve Limited ( (AU:RNV) ).

REHOVOT, Israel, Feb. 8, 2021 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN) today announced it has entered into a worldwide exclusive development and commercialization agreement for dermal ...

CollPlant announces positive results from non-clinical studies of its photocurable regenerative dermal and soft tissue filler: Rehovot, Israel Wednesday, October 1, 2025, 18:00 Hr ...

Further validation for Aroa’s Myriad™ from two clinical studies and peer-reviewed publications in Journal of Wound Care. One study shows high success rates, from use of Myriad™ in tissue ...

ReNerve is complementing its nerve repair products in the US with a new dermal and amniotic product range, already achieving its first sale and clinical use. Special Report: ReNerve has completed the ...

Developer of products for peripheral nerve repair ReNerve has launched its Empliq range in the US after recently completing ...